Interstitial Lung Disease in Systemic Sclerosis: Screening, Diagnosis and Management Trends
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.139 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Pankaj Kumar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a major driver of respiratory morbidity and mortality. Early recognition using high-resolution computed tomography (HRCT), pulmonary function testing (PFT), and structured risk stratification is increasingly emphasized in international guidance.
Aim
To evaluate screening yield, diagnostic patterns, severity distribution and contemporary management trends among systemic sclerosis patients assessed for ILD at Government Medical College and Hospital, Purnea, Bihar.
Methods
This prospective observational study included 65 consecutive patients fulfilling clinical criteria for systemic sclerosis between 5 April 2025 and 31 March 2026. All patients underwent symptom assessment, modified Rodnan skin scoring, autoantibody testing where available, spirometry with diffusing capacity, sixminute walk testing, transthoracic echocardiography and HRCT chest. ILD extent was categorized as absent, limited (
Zitieren
APA
Kumar, P., & Prakash, P. (2026). Interstitial Lung Disease in Systemic Sclerosis: Screening, Diagnosis and Management Trends. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.139
Vancouver
Kumar P, Prakash P. Interstitial Lung Disease in Systemic Sclerosis: Screening, Diagnosis and Management Trends. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.139
BibTeX
@article{Kumar2026,
author = {Kumar, Pankaj and Prakash, Prem},
title = {Interstitial Lung Disease in Systemic Sclerosis: Screening, Diagnosis and Management Trends},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.139}
}
EUVIMED